Sex-specific microRNAs in women with diabetes and left ventricular diastolic dysfunction or HFpEF associate with microvascular injury

Sci Rep. 2020 Aug 18;10(1):13945. doi: 10.1038/s41598-020-70848-8.

Abstract

Left ventricular diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction (HFpEF) are microcirculation defects following diabetes mellitus (DM). Unrecognized HFpEF is more prevalent in women with diabetes compared to men with diabetes and therefore sex-specific diagnostic strategies are needed. Previously, we demonstrated altered plasma miRs in DM patients with microvascular injury [defined by elevated plasma Angiopoietin-2 (Ang-2) levels]. This study hypothesized the presence of sex-differences in plasma miRs and Ang-2 in diabetic (female) patients with LVDD or HFpEF. After a pilot study, we assessed 16 plasma miRs in patients with LVDD (n = 122), controls (n = 244) and female diabetic patients (n = 10). Subsequently, among these miRs we selected and measured plasma miR-34a, -224 and -452 in diabetic HFpEF patients (n = 53) and controls (n = 52). In LVDD patients, miR-34a associated with Ang-2 levels (R2 0.04, R = 0.21, p = 0.001, 95% CI 0.103-0.312), with plasma levels being diminished in patients with DM, while women with an eGFR < 60 ml/min and LVDD had lower levels of miR-34a, -224 and -452 compared to women without an eGFR < 60 ml/min without LVDD. In diabetic HFpEF women (n = 28), plasma Ang-2 levels and the X-chromosome located miR-224/452 cluster increased compared to men. We conclude that plasma miR-34a, -224 and -452 display an association with the microvascular injury marker Ang-2 and are particularly targeted to women with LVDD or HFpEF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angiopoietin-2 / analysis
  • Angiopoietin-2 / blood
  • Biomarkers / blood
  • Diabetes Complications / genetics
  • Diabetes Mellitus / genetics
  • Female
  • Heart Failure / genetics*
  • Heart Failure / physiopathology
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Pilot Projects
  • Sex Characteristics
  • Stroke Volume / genetics
  • Stroke Volume / physiology
  • Ventricular Dysfunction, Left / genetics*
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left / genetics
  • Ventricular Function, Left / physiology

Substances

  • Angiopoietin-2
  • Biomarkers
  • MIRN224 microRNA, human
  • MIRN34 microRNA, human
  • MIRN452 microRNA, human
  • MicroRNAs